Schrodinger, Inc. $SDGR Shares Sold by ARK Investment Management LLC

ARK Investment Management LLC reduced its position in Schrodinger, Inc. (NASDAQ:SDGRFree Report) by 4.4% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 1,872,677 shares of the company’s stock after selling 86,584 shares during the period. ARK Investment Management LLC owned 2.54% of Schrodinger worth $37,566,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Dimensional Fund Advisors LP lifted its holdings in shares of Schrodinger by 14.7% during the third quarter. Dimensional Fund Advisors LP now owns 851,389 shares of the company’s stock worth $17,079,000 after purchasing an additional 108,868 shares during the period. Aster Capital Management DIFC Ltd boosted its holdings in Schrodinger by 212.4% during the third quarter. Aster Capital Management DIFC Ltd now owns 1,943 shares of the company’s stock worth $39,000 after buying an additional 1,321 shares in the last quarter. Fox Run Management L.L.C. purchased a new stake in shares of Schrodinger during the 3rd quarter worth approximately $357,000. Citigroup Inc. grew its holdings in shares of Schrodinger by 122.5% in the 3rd quarter. Citigroup Inc. now owns 155,209 shares of the company’s stock worth $3,113,000 after acquiring an additional 85,448 shares during the period. Finally, ANTIPODES PARTNERS Ltd raised its holdings in Schrodinger by 292.3% during the third quarter. ANTIPODES PARTNERS Ltd now owns 4,912 shares of the company’s stock worth $99,000 after purchasing an additional 3,660 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Schrodinger Trading Up 5.0%

Shares of NASDAQ:SDGR opened at $13.12 on Thursday. The firm has a market cap of $966.55 million, a price-to-earnings ratio of -9.24 and a beta of 1.57. The stock’s 50-day moving average price is $14.99 and its two-hundred day moving average price is $17.68. Schrodinger, Inc. has a 12-month low of $11.11 and a 12-month high of $27.63.

Schrodinger (NASDAQ:SDGRGet Free Report) last released its quarterly earnings data on Wednesday, February 25th. The company reported $0.44 EPS for the quarter, topping analysts’ consensus estimates of ($0.13) by $0.57. The business had revenue of $87.24 million during the quarter, compared to the consensus estimate of $83.66 million. Schrodinger had a negative return on equity of 29.47% and a negative net margin of 40.37%.The business’s revenue for the quarter was up 4.7% on a year-over-year basis. During the same period in the prior year, the firm posted ($0.24) EPS. As a group, research analysts forecast that Schrodinger, Inc. will post -2.37 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on the company. TD Cowen restated a “buy” rating on shares of Schrodinger in a research report on Thursday, January 8th. Wall Street Zen upgraded shares of Schrodinger from a “sell” rating to a “hold” rating in a research report on Saturday, January 31st. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Schrodinger in a report on Friday, January 9th. KeyCorp dropped their price objective on shares of Schrodinger from $28.00 to $25.00 and set an “overweight” rating for the company in a research note on Thursday, January 8th. Finally, UBS Group began coverage on Schrodinger in a research report on Wednesday, January 7th. They set a “neutral” rating and a $18.00 price objective for the company. Four research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Schrodinger has an average rating of “Hold” and a consensus target price of $21.75.

Read Our Latest Stock Analysis on Schrodinger

Schrodinger Company Profile

(Free Report)

Schrödinger, Inc is a life sciences and materials discovery company that specializes in the application of physics-based computational platforms to accelerate drug discovery and advanced materials design. Founded in 1990 by Professor Richard A. Friesner, Schrödinger has developed a suite of proprietary software tools—such as Maestro for molecular modeling, Glide for molecular docking and Jaguar for quantum chemistry calculations—that enable scientists to predict molecular behavior with high accuracy.

Featured Stories

Institutional Ownership by Quarter for Schrodinger (NASDAQ:SDGR)

Receive News & Ratings for Schrodinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Schrodinger and related companies with MarketBeat.com's FREE daily email newsletter.